LMO1

Information LMO1

Description

This locus encodes a transcriptional regulator that contains two cysteine-rich LIM domains but lacks a DNA-binding domain. LIM domains may play a role in protein interactions; thus the encoded protein may regulate transcription by competitively binding to specific DNA-binding transcription factors. Alterations at this locus have been associated with acute lymphoblastic T-cell leukemia. Chromosomal rearrangements have been observed between this locus and at least two loci, the delta subunit of the T-cell antigen receptor gene and the LIM domain binding 1 gene. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2012]

Full Name

LIM domain only 1

Source NCBI

ReMap Statistics

Datasets
1
Biotypes
1
Peaks
43,562
Non-redundant peaks
43,562

TF Classification

Super Class
NA
Class
NA
Familly
NA
Sub Familly
NA

Source TFClass

External IDs

JASPAR
Ensembl
ENSG00000166407
UniProt
P25800
Genevisible
P25800
RefSeq
NM_001270428
Aliases
RBTN1; RHOM1; TTG1
All peaks LMO1
Download BED file
Non redundant peaks LMO1
Download BED file
SEQUENCES LMO1
Download FASTA file
DOWNLOAD All ReMap
Got to catalogue

Datasets Table for LMO1

Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks
LMO1 Jurkat GEO Homo sapiens GSE94391 43,562
Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.